LINGO-1 (Leucine-rich repeat- and Ig domain-containing nogo receptor-interacting protein 1) is a transmembrane protein of the leucine-rich repeat (LRR) family, ribonuclease inhibitor subfamily. The four known LINGO proteins contain LRR and IgCAM domains in the extracellular portion and share 44-61% aa identity. LINGO-1 is restricted to the nervous system and is concentrated in the brain as a component of the NgR1/p75 and NgR1/Taj (Troy) signaling complexes. LINGO-1 negatively regulates neurite outgrowth and myelination, and is highly conserved, showing 99% aa identity between human, mouse and rat.
Human LINGO-1 (NP_116197) VersaClone cDNA
R&D Systems | Catalog # RDC1089
Loading...
Loading...
Formulation, Preparation, and Storage
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Background: LINGO-1
Long Name
Leucine-rich Repeat And Ig Domain Containing Nogo Receptor-Interacting Protein 1
Alternate Names
LERN1, LINGO1, LRRN6A
Entrez Gene IDs
84894 (Human)
Gene Symbol
LINGO1
UniProt
Additional LINGO-1 Products
Product Documents for Human LINGO-1 (NP_116197) VersaClone cDNA
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human LINGO-1 (NP_116197) VersaClone cDNA
For research use only
Related Research Areas
Customer Reviews for Human LINGO-1 (NP_116197) VersaClone cDNA
There are currently no reviews for this product. Be the first to review Human LINGO-1 (NP_116197) VersaClone cDNA and earn rewards!
Have you used Human LINGO-1 (NP_116197) VersaClone cDNA?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Loading...